{"id":51479,"date":"2024-09-13T09:07:01","date_gmt":"2024-09-13T07:07:01","guid":{"rendered":"https:\/\/setterwalls.se\/?post_type=assignments&#038;p=51479"},"modified":"2024-09-17T14:29:00","modified_gmt":"2024-09-17T12:29:00","slug":"setterwalls-advised-ascelia-pharma-in-connection-with-a-fully-subscribed-rights-issue-of-units","status":"publish","type":"assignments","link":"https:\/\/setterwalls.se\/en\/case\/setterwalls-advised-ascelia-pharma-in-connection-with-a-fully-subscribed-rights-issue-of-units\/","title":{"rendered":"Setterwalls advised Ascelia Pharma in connection with a fully subscribed rights issue of units"},"content":{"rendered":"    <section class=\"block text bg-white\">\n        <div class=\"container container-sm\">\n            <div class=\"row\">\n                <div class=\"col-12\">\n                    <div class=\"editor-content\">\n                                                <p><strong>Setterwalls has advised Ascelia Pharma AB, listed on Nasdaq Stockholm, in connection with a fully subscribed rights issue of units.<\/strong><\/p>\n<p>Ascelia Pharma is a biotech company focused on orphan oncology treatments. The company develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates \u2013 Orviglance\u00ae and Oncoral \u2013 in clinical development. Ascelia Pharma has global headquarters in Malm\u00f6, Sweden, and is listed on Nasdaq Stockholm (ticker: ACE).<\/p>\n<p>Through the rights issue, Ascelia Pharma receives initial issue proceeds of approximately SEK 105 million before issue costs.<\/p>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":11,"featured_media":36357,"template":"","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":""},"class_list":["post-51479","assignments","type-assignments","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/assignments\/51479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/assignments"}],"about":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/types\/assignments"}],"author":[{"embeddable":true,"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/users\/11"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/media\/36357"}],"wp:attachment":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/media?parent=51479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}